In Utero Molecular-Targeted Drug Therapies: Translational Principles, Pharmacologic Considerations, and Emerging...

Area of Science:

• Molecular Medicine
• Pharmacology
• Fetal Medicine

Background:

• Advances in fetal diagnosis and molecular medicine enable new in utero therapeutic strategies.
• Fetal treatment is shifting from procedural interventions to pharmacologic approaches targeting disease mechanisms.
• This minimizes irreversible organ damage before birth.

Purpose of the Study:

• To review recent advances in in utero drug therapy.
• Focus on molecular-targeted approaches with emerging clinical or trial evidence.
• Highlight challenges and future directions for prenatal precision therapies.

Main Methods:

• Review of recent literature on in utero drug therapy.
• Focus on molecular-targeted approaches.
• Analysis of clinical and trial-level evidence.

Main Results:

• Demonstrated feasibility of achieving therapeutically relevant fetal drug exposure.
• Evidence strength varies across different therapeutic classes.
• Significant challenges identified in drug delivery, pharmacokinetics, pharmacodynamics, safety, and ethics.

Conclusions:

• Prenatal molecular therapeutics hold significant promise.
• Further prospective evaluation is essential.
• Integration of fetal imaging, genomics, ethics, and pharmacology is crucial for advancing prenatal precision therapies.